Proxima Bio, Inc. — Form D
Proxima Bio, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-21. The offering totals $88.5M, of which $86.3M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2026-01-21
- Form: D
- Accession: 0002104665-26-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $88.5M
- Amount sold: $86.3M
- Remaining: $2.2M
- Minimum investment: $1
- Investors: 11
- Date of first sale: 2026-01-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-570576
Issuer
- Name: Proxima Bio, Inc.
- CIK: 0002104665
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 116 E 16TH STREET FLOOR 12, NEW YORK, NY, 10003
- Phone: 212-516-8509
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Zachary Carpenter | Director | New York, NY |
| Alex Gasner | Director | New York, NY |
| Jason Pontin | Director | New York, NY |
| Evan Schwartz | Director | New York, NY |
| Zachary Carpenter | Executive Officer | New York, NY |
| John McFarland | Executive Officer | New York, NY |
| Jason Pontin | Related Person | New York, NY |
| Zachary Carpenter | Related Person | New York, NY |
| John McFarland | Related Person | New York, NY |
| Alex Gasner | Related Person | New York, NY |
Other filings by this issuer (1)
More